Growing prevalence of allergic diseases such as rhinitis and other form of allergies across the globe is projected to boost demand for the effective diagnosis aids in the market. These allergies mainly caused by the allergens in contact with including animals, house dust, weed pollens, and wild grass affecting the inflammation around and inside the nose. The key symptoms are nasal congestion, itching, continuous sneezing and itching inside eyes are stimulating improved medication market growth.
The global allergic rhinitis drugs market is expected to be around US$ 2.80 billion by 2028 at a CAGR of close to 4% during the forecast period.
Rising awareness about the allergic reactions and mode of frequent treatment to the patients is fuelling product demand at early stages in several countries. Early stage symptoms are easily detected and cured by the medicines majorly sold on over the counter in varied pharmacies propelling the revenue share.
Global allergic rhinitis drugs market is segregated on the basis of drug class as, antihistamines, intranasal corticosteroids, and immunotherapies. Based on distribution channel, the global allergic rhinitis drugs market is segmented as hospital pharmacies, retail pharmacies, and online pharmacies.
Global allergic rhinitis drugs market report provides geographic analysis covering regions such as North America, Europe, Asia Pacific, and Rest of World. The allergic rhinitis drugs market for each region is further segmented for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
Competitive Rivalry
Sun Pharmaceuticals, Dr Reddy’s Laboratories, Adamis Pharmaceuticals, Array BioPharma, Lupin Pharmaceuticals, Allergy Therapeutics, GlaxoSmithKline plc, ALK-Abello, and Mylan NV are among the major players in the global allergic rhinitis drugs market share. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Allergic Rhinitis Drugs Market has been segmented as below:
Allergic Rhinitis Drugs Market, By Drug Class
Allergic Rhinitis Drugs Market, By Distribution Channel
Allergic Rhinitis Drugs Market, By Region
The report covers:
Report scope:
Global allergic rhinitis drugs market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global allergic rhinitis drugs market share. Major industry players with significant revenue share include Sun Pharmaceuticals, Dr Reddy’s Laboratories, Adamis Pharmaceuticals, Lupin Pharmaceuticals, Array BioPharma, Allergy Therapeutics, GlaxoSmithKline plc, ALK-Abello, and Mylan NV.
Reasons to Buy this Report:
Customization:
Customized report as per the requirement can be offered with appropriate recommendations
Below are our New Reports :-
Biosimulation Technology Market
Cholesterol Screening/ Cholesterol Lab Testing Services Market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.2.1. Driver 1
4.2.2. Driver 2
4.2.3. Driver 3
4.3. Restraints
4.3.1. Restraint 1
4.3.2. Restraint 2
4.4. Opportunities
4.4.1. Opportunity 1
4.4.2. Opportunity 2
4.5. Challenges
4.5.1. Challenge 1
4.5.2. Challenge 2
5. Allergic Rhinitis Drugs Market, By Drug Class
5.1. Key Points
5.2. Antihistamines
5.3. Intranasal Corticosteroids
5.4. Immunotherapies
6. Allergic Rhinitis Drugs Market, By Distribution Channel
6.1. Key Points
6.2. Hospital Pharmacies
6.3. Retail Pharmacies
6.4. Online Pharmacies
7. Competitive Landscape
7.1. Introduction
7.2. Recent Developments
7.2.1. Mergers &Acquisitions
7.2.2. New Product Developments
7.2.3. Portfolio/Production Capacity Expansions
7.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
7.2.5. Others
8. Company Profile
8.1. Sun Pharmaceuticals
8.1.1. Company Overview
8.1.2. Product/Service Landscape
8.1.3. Financial Overview
8.1.4. Recent Developments
8.2. Dr Reddy’s Laboratories
8.2.1. Company Overview
8.2.2. Product/Service Landscape
8.2.3. Financial Overview
8.2.4. Recent Developments
8.3. Adamis Pharmaceuticals
8.3.1. Company Overview
8.3.2. Product/Service Landscape
8.3.3. Financial Overview
8.3.4. Recent Developments
8.4. Array BioPharma
8.4.1. Company Overview
8.4.2. Product/Service Landscape
8.4.3. Financial Overview
8.4.4. Recent Developments
8.5. Lupin Pharmaceuticals
8.5.1. Company Overview
8.5.2. Product/Service Landscape
8.5.3. Financial Overview
8.5.4. Recent Developments
8.6. Array BioPharma
8.6.1. Company Overview
8.6.2. Product/Service Landscape
8.6.3. Financial Overview
8.6.4. Recent Developments
8.7. Allergy Therapeutics
8.7.1. Company Overview
8.7.2. Product/Service Landscape
8.7.3. Financial Overview
8.7.4. Recent Developments
8.8. GlaxoSmithKline plc
8.8.1. Company Overview
8.8.2. Product/Service Landscape
8.8.3. Financial Overview
8.8.4. Recent Developments
8.9. ALK-Abello
8.9.1. Company Overview
8.9.2. Product/Service Landscape
8.9.3. Financial Overview
8.9.4. Recent Developments
8.10. Mylan NV.
8.10.1. Company Overview
8.10.2. Product/Service Landscape
8.10.3. Financial Overview
8.10.4. Recent Developments
The Allergic Rhinitis Drugs Market has been segmented as below:
Allergic Rhinitis Drugs Market, By Drug Class
Allergic Rhinitis Drugs Market, By Distribution Channel
Allergic Rhinitis Drugs Market, By Region
SUBSCRIBE TO OUR NEWSLETTERS
